ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NRIX announcements Nurix Therapeutics Inc announcements and dividends declared NASDAQ

Nurix Therapeutics Inc Complete list of announcements declared & dividend announcements by Nurix Therapeutics Inc NRIX

Nurix Therapeutics Inc NRIX listed on NASDAQ and deals in

Announcements and dividends declared by Nurix Therapeutics Inc NRIX

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates
Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -4.22% and -57.21%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 08 April 2026

Nurix Therapeutics to Host Webcast on Phase 1 Clinical Trial Data for Bexobrutideg (NX-5948) at EHA2025
Nurix Therapeutics will host a webcast on June 12, 2025, to discuss Phase 1 trial data for bexobrutideg.
Announcement as on 06 June 2025

Nurix Therapeutics Secures Million License Extension from Sanofi for STAT6 Program
Nurix Therapeutics secures a million license extension from Sanofi for its STAT6 program, totaling 7 million to date.
Announcement as on 02 June 2025

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates
Nurix Therapeutics, Inc. (NRIX) came out with a quarterly loss of [CO].76 per share versus the Zacks Consensus Estimate of a loss of [CO].80. This compares to loss of [CO].75 per share a year ago. These figures are adjusted for non-recu
Announcement as on 10 April 2024

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates
Nurix Therapeutics, Inc. (NRIX) came out with a quarterly loss of [CO].76 per share versus the Zacks Consensus Estimate of a loss of [CO].80. This compares to loss of [CO].75 per share a year ago. These figures are adjusted for non-recu
Announcement as on 10 April 2024

Announcements by Nurix Therapeutics Inc first page | Next page |

NRIX Nurix Therapeutics Inc current price & indicator signals

Moving Averages for Nurix Therapeutics Inc

  • 5Day Average: 16.02
  • 12Day Average: 15.68
  • 20Day Average: 15.42
  • 50Day Average: 15.72
  • 100Day Average: 16.96
  • 150Day Average: 14.77
  • 200Day Average: 13.81

NRIX Indicators & signals

Indicator MACD (12,26,9)

15.8, 15.69, -0.04
Indicator MACD is in positive zone

Indicator ADX (14)

18.92, 22.22, 15.15
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NRIX Nurix Therapeutics Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Tue Apr 2026 16.30 15.78 to 16.76 2.45% 0.95 times
13 Mon Apr 2026 15.91 15.90 to 16.80 -0.75% 0.72 times
10 Fri Apr 2026 16.03 16.02 to 16.62 -1.29% 0.85 times
09 Thu Apr 2026 16.24 15.47 to 16.50 4.1% 0.88 times
08 Wed Apr 2026 15.60 15.52 to 17.19 -4.59% 1.48 times
07 Tue Apr 2026 16.35 15.60 to 16.54 3.55% 1.29 times
06 Mon Apr 2026 15.79 15.42 to 16.88 1.81% 1.24 times
02 Thu Apr 2026 15.51 15.00 to 15.65 0.19% 0.86 times
01 Wed Apr 2026 15.48 15.29 to 16.10 -0.13% 0.67 times
31 Tue Mar 2026 15.50 15.03 to 16.22 5.66% 1.23 times
30 Mon Mar 2026 14.67 14.41 to 15.01 -0.61% 0.77 times
27 Fri Mar 2026 14.76 14.75 to 15.55 -4.96% 0.87 times

Videos related to: NRIX announcements Nurix Therapeutics Inc announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NRIX announcements Nurix Therapeutics Inc announcements and dividends declared NASDAQ

 

Back to top